Abstract
Background
Cardiovascular disease (CVD) and gallstones are reported to be strongly associated because both diseases are frequently part of a metabolic syndrome. Laparoscopic cholecystectomy (LC) has become the standard treatment for gallbladder disease around the world. Cardiovascular disease is considered as an absolute or relative contraindication for LC; however, clinical information regarding the applicability of LC for treating gallbladder disease in CVD patients is lacking. This study aims to assess the suitability of LC for the treatment of gallbladder disease in CVD patients.
Methods
The medical records of 66 patients with severe CVD (including valvular heart disease, ischemic heart disease, and heart failure) and gallbladder disease (CVD-group) who underwent LC between 1966 and 2005 were retrospectively reviewed. Furthermore, these data were compared with the clinical features and outcomes of 8,834 patients with gallbladder disease who underwent LC but did not have severe CVD (NCVD-group).
Results
Of the 8,900 patients with gallbladder disease undergoing LC, the 66 (0.74%) who comprised the CVD-group clearly exhibited advanced age, male predominance, higher blood urea nitrogen (BUN) levels, and a longer duration of hospitalization as compared with the NCVD-group patients. A longer duration of hospitalization and a higher incidence of acute cholecystitis and chronic cholecystitis were identified as independent factors differentiating the CVD-group patients, who had previously undergone open-heart surgery, from the NCVD-group patients who underwent LC. For the CVD-group patients, adjustment of anticoagulant therapy contributed to the longer duration of hospitalization, but postoperative complications did not. Advanced age and male predominance were identified as independent factors differentiating the patients who developed ischemic heart disease that required intervention from the NCVD-group patients undergoing LC. The operative morbidity and mortality rates of LC are likely to be similar when it is used to treat selected patients with severe CVD and gallbladder disease and when it is used to treat patients with gallbladder disease and no CVD.
Conclusions
Laparoscopic cholecystectomy is a suitable procedure for treating selected patients with severe CVD and gallbladder disease, and its operative morbidity and mortality rates are similar in these patients and in patients with gallbladder disease alone. Nevertheless, appropriate preoperative preparations and established operative techniques in the hands of an experienced surgeon are mandatory.
Similar content being viewed by others
References
Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia NC et al (2005) Strong association between gallstones and cardiovascular disease. Am J Gastroenterol 100(4):827–830
Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D et al (2005) Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 11(11):1653–1657
Apstein MD, Carey MC (1990) Pathogenesis of cholesterol gallstones: a parsimonious hypothesis. Eur J Clin Invest 26:343–352
Mendez-Sanchez N, Chavez-Tapia NC, Uribe M (2003) The role of dietary fats in the pathogenesis of gallstones. Front Biosci 8:420–427
Cuschieri A, Dubois F, Mouiel J et al (1991) The European experience with laparoscopic cholecystectomy. Am J Surg 161:385–387
Salameh JR, Franklin ME Jr (2004) Acute cholecystitis and severe ischemic cardiac disease: is laparoscopy indicated? JSLS 8(1):61–64
Hojs R (1995) Cholecystolithiasis in patients with end-stage renal disease treated with haemodialysis: a study of prevalence. Am J Nephrol 15(1):15–17
Galizia G, Prizio G, Lieto E et al (2001) Hemodynamic and pulmonary changes during open, carbon dioxide pneumoperitoneum and abdominal wall-lifting cholecystectomy. A prospective, randomized study. Surg Endosc 15(5):477–483
Hein HA, Joshi GP, Ramsay MA, Fox LG, Gawey BJ, Hellman CL, Arnold JC (1997) Hemodynamic changes during laparoscopic cholecystectomy in patients with severe cardiac disease. J Clin Anesth 9(4):261–265
Rist M, Hemmerling TM, Rauh R, Siebzehnrübl E, Jacobi KE (2001) Influence of pneumoperitoneum and patient positioning on preload and splanchnic blood volume in laparoscopic surgery of the lower abdomen. J Clin Anesth 13(4):244–249
Yeh C-N, Chen M-F, Jan Y-Y (2005) Laparoscopic cholecystectomy for 58 end stage renal disease patients. Surg Endosc 19(7):915–918
Yeh C-N, Chen M-F, Jan Y-Y (2002) Laparoscopic cholecystectomy in 226 cirrhotic patients: experience of a single center in Taiwan. Surg Endosc 16(11):1583–1587
Leandros E, Gomatos IP, Mami P, Kastellanos E, Albanopoulos K, Konstadoulakis MM (2005) Elective laparoscopic cholecystectomy for symptomatic gallstone disease in patients receiving anticoagulant therapy. J Laparoendosc Adv Surg Tech A 15(4):357–360
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, YY., Yeh, CN., Lee, HL. et al. Laparoscopic Cholecystectomy for Gallbladder Disease in Patients with Severe Cardiovascular Disease. World J Surg 33, 1720–1726 (2009). https://doi.org/10.1007/s00268-009-0072-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-0072-9